Vercise™ DBS Dystonia Prospective Study
About the study
To compile characteristics of real-world outcomes of Boston Scientific Corporation's commercially approved VerciseTM Deep Brain Stimulation (DBS) Systems for the treatment of dystonia.
Who can take part
You may be eligible to participate in the study if you meet the following criteria:
INCLUSION CRITERIA
Inclusion Criteria (IC):
- IC1. Meets criteria established in the locally applicable Vercise System Directions for Use (DFU) for dystonia.
- IC2. At least 7 years old. Parent or guardian consent is required in patients who are younger than 18 years at the time of consent.
EXCLUSION CRITERIA
Exclusion Criteria (EC):
* EC1. Meets any contraindication in the Vercise System locally applicable Directions for Use.
Study Locations
Enter your ZIP code/Postal code/PIN code to locate study sites near you:
How to Apply
Contact the study center to learn if this study is a good match for you.
Study Details
Contition
Dystonia
Age
7+
Participants Needed
300
Est. Completion Date
Dec 31, 2030
Treatment Type
OBSERVATIONAL
Sponsor
Boston Scientific Corporation
ClinicalTrials.gov NCT Identifier
NCT02686125
Study Number
A4012
Understanding Clinical Trials
Get answers to your questions about clinical trials.What is clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?